94
Views
33
CrossRef citations to date
0
Altmetric
Original Research

Sildenafil potentiates the antitumor activity of cisplatin by induction of apoptosis and inhibition of proliferation and angiogenesis

, &
Pages 3661-3672 | Published online: 16 Nov 2016

References

  • FajardoAMPiazzaGATinsleyHNThe role of cyclic nucleotide signaling pathways in cancer: targets for prevention and treatmentCancers (Basel)20146143645810.3390/cancers601043624577242
  • EskandariNMirmosayyebOBordbariGBastanRYousefiZAndalibAA short review on structure and role of cyclic-3′,5′-adenosine monophosphate-specific phosphodiesterase 4 as a treatment toolJ Res Pharm Pract20154417518110.4103/2279-042X.16704326645022
  • PiazzaGAThompsonWJPamukcuRExisulind, a novel proapoptotic drug, inhibits rat urinary bladder tumorigenesisCancer Res200161103961396811358813
  • WhiteheadCMEarleKAFetterJExisulind-induced apoptosis in a non-small cell lung cancer orthotopic lung tumor model augments docetaxel treatment and contributes to increased survivalMol Cancer Ther20032547948812748310
  • BlackKLYinDOngJMPDE5 inhibitors enhance tumor permeability and efficacy of chemotherapy in a rat brain tumor modelBrain Res2008123029030210.1016/j.brainres.2008.06.12218674521
  • AbadiAHAbouel-EllaDAAhmedNSSynthesis of novel tadalafil analogues and their evaluation as phosphodiesterase inhibitors and anticancer agentsArzneimittelforschung200959841542119813465
  • BaroneICatalanoSCampanaAExpression and function of phosphodiesterase type 5 in human breast cancer cell lines and tissues: implications for targeted therapyClin Cancer Res201622922712282 doi: 1078-0432.CCR-15-190026667489
  • Tahsili-FahadanPYahyavi-Firouz-AbadiNOrandiAHEsmaeiliBBassedaZDehpourARRewarding properties of sildenafil citrate in mice: role of the nitric oxide-cyclic GMP pathwayPsychopharmacology2006185220120716425058
  • LukowskiRKriegTRybalkinSDBeavoJHofmannFTurning on cGMP-dependent pathways to treat cardiac dysfunctions: boom, bust, and beyondTrends Pharmacol Sci201435840441310.1016/j.tips.2014.05.00324948380
  • BehmenburgFDorschMHuhnRImpact of mitochondrial Ca2+-sensitive potassium (mBKCa) channels in sildenafil-induced cardioprotection in ratsPLoS One20151012e014473710.1371/journal.pone.014473726671662
  • de AlmeidaLSBarbozaJRFreitasFPSildenafil prevents renal dysfunction in contrast media-induced nephropathy in Wistar ratsHum Exp Toxicol Epub2016120 pii:0960327115626582
  • ToblliJECaoGAngerosaMRiveroMLong-term phosphodiesterase 5 inhibitor administration reduces inflammatory markers and heat-shock proteins in cavernous tissue of Zucker diabetic fatty rat (ZDF/fa/fa)Int J Impot Res201527518219010.1038/ijir.2015.1326202338
  • GokakinAKAtabeyMDeveciKThe effects of sildenafil in liver and kidney injury in a rat model of severe scald burn: a biochemical and histopathological studyUlus Travma Acil Cerrahi Derg201420531932710.5505/tjtes.2014.3958625541842
  • NoelSDhoogheBLealTPDE5 inhibitors as potential tools in the treatment of cystic fibrosisFront Pharmacol2012316723024633
  • ZahranMHHusseinAMBarakatNSildenafil activates antioxidant and antiapoptotic genes and inhibits proinflammatory cytokine genes in a rat model of renal ischemia/reperfusion injuryInt Urol Nephrol201547111907191510.1007/s11255-015-1099-526377490
  • SavvanisSNastosCTasoulisMKSildenafil attenuates hepatocellular injury after liver ischemia reperfusion in rats: a preliminary studyOxid Med Cell Longev2014201416194210.1155/2014/16194224999378
  • MeiXLYangYZhangYJSildenafil inhibits the growth of human colorectal cancer in vitro and in vivoAm J Cancer Res20155113311332426807313
  • SarfatiMMateoVBaudetSSildenafil and vardenafil, types 5 and 6 phosphodiesterase inhibitors, induce caspase-dependent apoptosis of B-chronic lymphocytic leukemia cellsBlood2003101126526912393651
  • Abdel MoneimAEOthmanMSArefAMAzadirachta indica attenuates cisplatin-induced nephrotoxicity and oxidative stressBiomed Res Int2014201464713110.1155/2014/64713125162019
  • Abdel MoneimAEAzadirachta indica attenuates cisplatin-induced neurotoxicity in ratsIndian J Pharmacol201446331632110.4103/0253-7613.13218224987180
  • CepedaVFuertesMACastillaJAlonsoCQuevedoCPerezJMBiochemical mechanisms of cisplatin cytotoxicityAnticancer Agents Med Chem20077131817266502
  • OuYWZhaoZTWuCYXuBNSongYMZhanQMMig-2 attenuates cisplatin-induced apoptosis of human glioma cells in vitro through AKT/JNK and AKT/p38 signaling pathwaysActa Pharmacol Sin20143591199120610.1038/aps.2014.6025152024
  • NovohradskyVZerzankovaLStepankovaJAntitumor platinum(IV) derivatives of oxaliplatin with axial valproato ligandsJ Inorg Biochem2014140727910.1016/j.jinorgbio.2014.07.00425063910
  • OhGSKimHJShenACisplatin-induced kidney dysfunction and perspectives on improving treatment strategiesElectrolyte Blood Press2014122556510.5049/EBP.2014.12.2.5525606044
  • WensingKUCiarimboliGSaving ears and kidneys from cisplatinAnticancer Res201333104183418824122981
  • National Research CouncilGuide for the Care and Use of Laboratory AnimalsWashington, DCNational Academy Press19962107
  • LeeIBoucherYJainRKNicotinamide can lower tumor interstitial fluid pressure: mechanistic and therapeutic implicationsCancer Res19925211323732401534273
  • BilalovicNSandstadBGolouhRNeslandJMSelakITorlakovicEECD10 protein expression in tumor and stromal cells of malignant melanoma is associated with tumor progressionMod Pathol200417101251125815205682
  • SmetsLABoutBBrouwerMTulpACytotoxic effects of dexamethasone restricted to noncycling, early G1-phase cells of L1210 leukemiaJ Cell Physiol198311633974036885934
  • SkehanPStorengRScudieroDNew colorimetric cytotoxicity assay for anticancer-drug screeningJ Natl Cancer Inst19908213110711122359136
  • DasADurrantDMitchellCSildenafil increases chemotherapeutic efficacy of doxorubicin in prostate cancer and ameliorates cardiac dysfunctionProc Natl Acad Sci U S A201010742182021820710.1073/pnas.100696510720884855
  • O’DonovanNCrownJStunellHCaspase 3 in breast cancerClin Cancer Res20039273874212576443
  • SleeEAAdrainCMartinSJSerial killers: ordering caspase activation events in apoptosisCell Death Differ19996111067107410578175
  • BlancCDeverauxQLKrajewskiSCaspase-3 is essential for procaspase-9 processing and cisplatin-induced apoptosis of MCF-7 breast cancer cellsCancer Res200060164386439010969782
  • YangXHSladekTLLiuXButlerBRFroelichCJThorADReconstitution of caspase 3 sensitizes MCF-7 breast cancer cells to doxorubicin- and etoposide-induced apoptosisCancer Res200161134835411196185
  • QuinnCMWrightNAThe clinical assessment of proliferation and growth in human tumours: evaluation of methods and applications as prognostic variablesJ Pathol19901602931022181096
  • ShapiroHMFlow cytometry of DNA content and other indicators of proliferative activityArch Pathol Lab Med198911365915972471483
  • BasergaRThe cell cycleN Engl J Med198130484534596161307
  • GoliasCHCharalabopoulosACharalabopoulosKCell proliferation and cell cycle control: a mini reviewInt J Clin Pract200458121134114115646411
  • von HerbayASiegBSchurmannGHofmannWJBetzlerMOttoHFProliferative activity of neuroendocrine tumours of the gastroenteropancreatic endocrine system: DNA flow cytometric and immunohistological investigationsGut19913289499531885079
  • SteckKel-NaggarAKComparative flow cytometric analysis of Ki-67 and proliferating cell nuclear antigen (PCNA) in solid neoplasmsCytometry19941732582657851161
  • ShioharaSShiozawaTMiyamotoTExpression of cyclins, p53, and Ki-67 in cervical squamous cell carcinomas: overexpression of cyclin A is a poor prognostic factor in stage Ib and II diseaseVirchows Arch2005446662663315891905
  • InwaldECKlinkhammer-SchalkeMHofstadterFKi-67 is a prognostic parameter in breast cancer patients: results of a large population-based cohort of a cancer registryBreast Cancer Res Treat2013139253955210.1007/s10549-013-2560-823674192
  • RaicaMCimpeanAMRibattiDAngiogenesis in pre-malignant conditionsEur J Cancer200945111924193410.1038/sj.bjc.660473319406633
  • GriffioenAWMolemaGAngiogenesis: potentials for pharmacologic intervention in the treatment of cancer, cardiovascular diseases, and chronic inflammationPharmacol Rev200052223726810835101
  • FerraraNRole of vascular endothelial growth factor in the regulation of angiogenesisKidney Int199956379481410469350
  • ZhangRWangLZhangLNitric oxide enhances angiogenesis via the synthesis of vascular endothelial growth factor and cGMP after stroke in the ratCirc Res200392330831312595343
  • TaşAAtasoyNÖzbekHEffects of sildenafil citrate (Viagra) in the early phase of healing process in open wounds induced experimentally in dogsActa Vet Brno20037227327710.2754/avb200372020273
  • FajardoLFKwanHHKowalskiJPrionasSDAllisonACDual role of tumor necrosis factor-alpha in angiogenesisAm J Pathol199214035395441372154
  • LandskronGDe la FuenteMThuwajitPThuwajitCHermosoMAChronic inflammation and cytokines in the tumor microenvironmentJ Immunol Res2014201414918510.1155/2014/14918524901008
  • Frater-SchroderMRisauWHallmannRGautschiPBohlenPTumor necrosis factor type alpha, a potent inhibitor of endothelial cell growth in vitro, is angiogenic in vivoProc Natl Acad Sci U S A198784155277528110.1073/pnas.84.15.52772440047
  • LeibovichSJPolveriniPJShepardHMWisemanDMShivelyVNuseirNMacrophage-induced angiogenesis is mediated by tumour necrosis factor-alphaNature198732961406306322443857
  • LiBVincentACatesJBrantley-SiedersDMPolkDBYoungPPLow levels of tumor necrosis factor alpha increase tumor growth by inducing an endothelial phenotype of monocytes recruited to the tumor siteCancer Res200969133834810.1158/0008-5472.CAN-08-156519118019
  • SatoNFukudaKNariuchiHSagaraNTumor necrosis factor inhibiting angiogenesis in vitroJ Natl Cancer Inst1987796138313912447319
  • SchweigererLMalersteinBGospodarowiczDTumor necrosis factor inhibits the proliferation of cultured capillary endothelial cellsBiochem Biophys Res Commun19871433997100410.1016/0006-291X(87)90350-02436621
  • KarakoyunBUsluUErcanFThe effect of phosphodiesterase-5 inhibition by sildenafil citrate on inflammation and apoptosis in rat experimental colitisLife Sci20118911–1240240710.1016/j.lfs.2011.07.00521806998
  • HubeFLeeYMRohrigKHaunerHThe phosphodiesterase inhibitor IBMX suppresses TNF-alpha expression in human adipocyte precursor cells: a possible explanation for its adipogenic effectHorm Metab Res199931635936210437623
  • TinsleyHNGaryBDKeetonABSulindac sulfide selectively inhibits growth and induces apoptosis of human breast tumor cells by phosphodiesterase 5 inhibition, elevation of cyclic GMP, and activation of protein kinase GMol Cancer Ther20098123331334010.1158/1535-7163.MCT-09-075819996273
  • TinsleyHNGaryBDKeetonABLuWLiYPiazzaGAInhibition of PDE5 by sulindac sulfide selectively induces apoptosis and attenuates oncogenic Wnt/beta-catenin-mediated transcription in human breast tumor cellsCancer Prev Res (Phila)2011481275128410.1158/1940-6207.CAPR-11-009521505183
  • FallahianFKarami-TehraniFSalamiSAghaeiMCyclic GMP induced apoptosis via protein kinase G in oestrogen receptor-positive and -negative breast cancer cell linesFEBS J2011278183360336910.1111/j.1742-4658.2011.08260.x21777390
  • AbadiAHGaryBDTinsleyHNPiazzaGAAbdel-HalimMSynthesis, molecular modeling and biological evaluation of novel tadalafil analogues as phosphodiesterase 5 and colon tumor cell growth inhibitors, new stereochemical perspectiveEur J Med Chem20104541278128610.1016/j.ejmech.2009.10.04620206015